RevoDx
Influenza A H1N1(pdm09) qPCR Kit
Influenza A H1N1 (pdm09), also referred to as pandemic H1N1, emerged as a novel strain of the influenza virus in 2009, leading to a global pandemic. This virus is a reassortant strain, meaning it contains genetic material from multiple influenza viruses. After the 2009 pandemic, H1N1 (pdm09) became a part of the seasonal influenza viruses, circulating globally alongside other influenza A (H3N2) and influenza B strains. Early diagnosis is crucial for effective treatment, outbreak control, and distinguishing H1N1 from other respiratory infections. The gold-standard diagnostic method is RT-PCR, which detects viral RNA with high sensitivity. The RevoDx Influenza A H1N1 (pdm09) qPCR Kit offers fast, accurate, and specific detection, making it a valuable tool for clinical and public health use.
Intended Use
RevoDx Influenza A H1N1 (pdm09) qPCR Kit is a real-time PCR test intended for the qualitative detection of Influenza A H1N1 (pdm09) RNA.
Features
- Single tube
- Ready-to-use kit
Human RNase P as an internal control - CE-IVD marked
- Assay duration: 60 mins
- The Limit of Detection (LoD) value is 69 copies/mL
- Diagnostic specificity is ≥ 99 %
- No cross-reactivity with the potential cross-reactive markers shown using both in silico analysis and wet testing.
Ordering Information